Report Detail

Request for Sample of this report

Pharma & Healthcare Global Nuclear Medicine/Radiopharmaceutic Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025

  • RnM3920767
    • |
  • 10 March, 2020
    • |
  • Global
    • |
  • 109 Pages
    • |
  • GIR (Global Info Research)
    • |
  • Pharma & Healthcare

Market Overview
The global Nuclear Medicine/Radiopharmaceutic market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

The Nuclear Medicine/Radiopharmaceutic market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Nuclear Medicine/Radiopharmaceutic market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Nuclear Medicine/Radiopharmaceutic market has been segmented into
Tc-99
I-123/131
In-111
Xe-133
Th-201
Ga-67
Other

By Application, Nuclear Medicine/Radiopharmaceutic has been segmented into:
Diagnostic
Therapeutic

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Nuclear Medicine/Radiopharmaceutic market presented in the report. This section sheds light on the sales growth of different regional and country-level Nuclear Medicine/Radiopharmaceutic markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Nuclear Medicine/Radiopharmaceutic market.

The report offers in-depth assessment of the growth and other aspects of the Nuclear Medicine/Radiopharmaceutic market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)

Competitive Landscape and Nuclear Medicine/Radiopharmaceutic Market Share Analysis
Nuclear Medicine/Radiopharmaceutic competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Nuclear Medicine/Radiopharmaceutic sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Nuclear Medicine/Radiopharmaceutic sales, revenue and market share for each player covered in this report.

The major players covered in Nuclear Medicine/Radiopharmaceutic are:
GE Healthcare
Eli Lilly
Lantheus Medical Imaging
Bracco Imaging
Nordion
Mallinckrodt
China Isotope & Radiation
Jubilant Pharma
Bayer
SIEMENS
Yantai Dongcheng Biochemicals

Among other players domestic and global, Nuclear Medicine/Radiopharmaceutic market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Nuclear Medicine/Radiopharmaceutic product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Nuclear Medicine/Radiopharmaceutic, with price, sales, revenue and global market share of Nuclear Medicine/Radiopharmaceutic in 2018 and 2019.
Chapter 3, the Nuclear Medicine/Radiopharmaceutic competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Nuclear Medicine/Radiopharmaceutic breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Nuclear Medicine/Radiopharmaceutic market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Nuclear Medicine/Radiopharmaceutic sales channel, distributors, customers, research findings and conclusion, appendix and data source.


Table of Contents

    1 Market Overview

    • 1.1 Nuclear Medicine/Radiopharmaceutic Introduction
    • 1.2 Market Analysis by Type
      • 1.2.1 Overview: Global Nuclear Medicine/Radiopharmaceutic Revenue by Type: 2015 VS 2019 VS 2025
      • 1.2.2 Tc-99
      • 1.2.3 I-123/131
      • 1.2.4 In-111
      • 1.2.5 Xe-133
      • 1.2.6 Th-201
      • 1.2.7 Ga-67
      • 1.2.8 Other
    • 1.3 Market Analysis by Application
      • 1.3.1 Overview: Global Nuclear Medicine/Radiopharmaceutic Revenue by Application: 2015 VS 2019 VS 2025
      • 1.3.2 Diagnostic
      • 1.3.3 Therapeutic
    • 1.4 Overview of Global Nuclear Medicine/Radiopharmaceutic Market
      • 1.4.1 Global Nuclear Medicine/Radiopharmaceutic Market Status and Outlook (2015-2025)
      • 1.4.2 North America (United States, Canada and Mexico)
      • 1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
      • 1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
      • 1.4.5 South America, Middle East & Africa
    • 1.5 Market Dynamics
      • 1.5.1 Market Opportunities
      • 1.5.2 Market Risk
      • 1.5.3 Market Driving Force

    2 Manufacturers Profiles

    • 2.1 GE Healthcare
      • 2.1.1 GE Healthcare Details
      • 2.1.2 GE Healthcare Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.1.3 GE Healthcare SWOT Analysis
      • 2.1.4 GE Healthcare Product and Services
      • 2.1.5 GE Healthcare Nuclear Medicine/Radiopharmaceutic Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
    • 2.2 Eli Lilly
      • 2.2.1 Eli Lilly Details
      • 2.2.2 Eli Lilly Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.2.3 Eli Lilly SWOT Analysis
      • 2.2.4 Eli Lilly Product and Services
      • 2.2.5 Eli Lilly Nuclear Medicine/Radiopharmaceutic Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
    • 2.3 Lantheus Medical Imaging
      • 2.3.1 Lantheus Medical Imaging Details
      • 2.3.2 Lantheus Medical Imaging Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.3.3 Lantheus Medical Imaging SWOT Analysis
      • 2.3.4 Lantheus Medical Imaging Product and Services
      • 2.3.5 Lantheus Medical Imaging Nuclear Medicine/Radiopharmaceutic Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
    • 2.4 Bracco Imaging
      • 2.4.1 Bracco Imaging Details
      • 2.4.2 Bracco Imaging Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.4.3 Bracco Imaging SWOT Analysis
      • 2.4.4 Bracco Imaging Product and Services
      • 2.4.5 Bracco Imaging Nuclear Medicine/Radiopharmaceutic Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
    • 2.5 Nordion
      • 2.5.1 Nordion Details
      • 2.5.2 Nordion Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.5.3 Nordion SWOT Analysis
      • 2.5.4 Nordion Product and Services
      • 2.5.5 Nordion Nuclear Medicine/Radiopharmaceutic Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
    • 2.6 Mallinckrodt
      • 2.6.1 Mallinckrodt Details
      • 2.6.2 Mallinckrodt Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.6.3 Mallinckrodt SWOT Analysis
      • 2.6.4 Mallinckrodt Product and Services
      • 2.6.5 Mallinckrodt Nuclear Medicine/Radiopharmaceutic Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
    • 2.7 China Isotope & Radiation
      • 2.7.1 China Isotope & Radiation Details
      • 2.7.2 China Isotope & Radiation Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.7.3 China Isotope & Radiation SWOT Analysis
      • 2.7.4 China Isotope & Radiation Product and Services
      • 2.7.5 China Isotope & Radiation Nuclear Medicine/Radiopharmaceutic Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
    • 2.8 Jubilant Pharma
      • 2.8.1 Jubilant Pharma Details
      • 2.8.2 Jubilant Pharma Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.8.3 Jubilant Pharma SWOT Analysis
      • 2.8.4 Jubilant Pharma Product and Services
      • 2.8.5 Jubilant Pharma Nuclear Medicine/Radiopharmaceutic Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
    • 2.9 Bayer
      • 2.9.1 Bayer Details
      • 2.9.2 Bayer Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.9.3 Bayer SWOT Analysis
      • 2.9.4 Bayer Product and Services
      • 2.9.5 Bayer Nuclear Medicine/Radiopharmaceutic Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
    • 2.10 SIEMENS
      • 2.10.1 SIEMENS Details
      • 2.10.2 SIEMENS Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.10.3 SIEMENS SWOT Analysis
      • 2.10.4 SIEMENS Product and Services
      • 2.10.5 SIEMENS Nuclear Medicine/Radiopharmaceutic Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
    • 2.11 Yantai Dongcheng Biochemicals
      • 2.11.1 Yantai Dongcheng Biochemicals Details
      • 2.11.2 Yantai Dongcheng Biochemicals Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.11.3 Yantai Dongcheng Biochemicals SWOT Analysis
      • 2.11.4 Yantai Dongcheng Biochemicals Product and Services
      • 2.11.5 Yantai Dongcheng Biochemicals Nuclear Medicine/Radiopharmaceutic Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

    3 Sales, Revenue and Market Share by Manufacturer

    • 3.1 Global Nuclear Medicine/Radiopharmaceutic Sales and Market Share by Manufacturer (2018-2019)
    • 3.2 Global Nuclear Medicine/Radiopharmaceutic Revenue and Market Share by Manufacturer (2018-2019)
    • 3.3 Market Concentration Rate
      • 3.3.1 Top 3 Nuclear Medicine/Radiopharmaceutic Manufacturer Market Share in 2019
      • 3.3.2 Top 6 Nuclear Medicine/Radiopharmaceutic Manufacturer Market Share in 2019
    • 3.4 Market Competition Trend

    4 Global Market Analysis by Regions

    • 4.1 Global Nuclear Medicine/Radiopharmaceutic Sales, Revenue and Market Share by Regions
      • 4.1.1 Global Nuclear Medicine/Radiopharmaceutic Sales and Market Share by Regions (2015-2020)
      • 4.1.2 Global Nuclear Medicine/Radiopharmaceutic Revenue and Market Share by Regions (2015-2020)
    • 4.2 North America Nuclear Medicine/Radiopharmaceutic Sales and Growth Rate (2015-2020)
    • 4.3 Europe Nuclear Medicine/Radiopharmaceutic Sales and Growth Rate (2015-2020)
    • 4.4 Asia-Pacific Nuclear Medicine/Radiopharmaceutic Sales and Growth Rate (2015-2020)
    • 4.5 South America Nuclear Medicine/Radiopharmaceutic Sales and Growth Rate (2015-2020)
    • 4.6 Middle East and Africa Nuclear Medicine/Radiopharmaceutic Sales and Growth Rate (2015-2020)

    5 North America by Country

    • 5.1 North America Nuclear Medicine/Radiopharmaceutic Sales, Revenue and Market Share by Country
      • 5.1.1 North America Nuclear Medicine/Radiopharmaceutic Sales and Market Share by Country (2015-2020)
      • 5.1.2 North America Nuclear Medicine/Radiopharmaceutic Revenue and Market Share by Country (2015-2020)
    • 5.2 United States Nuclear Medicine/Radiopharmaceutic Sales and Growth Rate (2015-2020)
    • 5.3 Canada Nuclear Medicine/Radiopharmaceutic Sales and Growth Rate (2015-2020)
    • 5.4 Mexico Nuclear Medicine/Radiopharmaceutic Sales and Growth Rate (2015-2020)

    6 Europe by Country

    • 6.1 Europe Nuclear Medicine/Radiopharmaceutic Sales, Revenue and Market Share by Country
      • 6.1.1 Europe Nuclear Medicine/Radiopharmaceutic Sales and Market Share by Country (2015-2020)
      • 6.1.2 Europe Nuclear Medicine/Radiopharmaceutic Revenue and Market Share by Country (2015-2020)
    • 6.2 Germany Nuclear Medicine/Radiopharmaceutic Sales and Growth Rate (2015-2020)
    • 6.3 UK Nuclear Medicine/Radiopharmaceutic Sales and Growth Rate (2015-2020)
    • 6.4 France Nuclear Medicine/Radiopharmaceutic Sales and Growth Rate (2015-2020)
    • 6.5 Russia Nuclear Medicine/Radiopharmaceutic Sales and Growth Rate (2015-2020)
    • 6.6 Italy Nuclear Medicine/Radiopharmaceutic Sales and Growth Rate (2015-2020)

    7 Asia-Pacific by Regions

    • 7.1 Asia-Pacific Nuclear Medicine/Radiopharmaceutic Sales, Revenue and Market Share by Regions
      • 7.1.1 Asia-Pacific Nuclear Medicine/Radiopharmaceutic Sales and Market Share by Regions (2015-2020)
      • 7.1.2 Asia-Pacific Nuclear Medicine/Radiopharmaceutic Revenue and Market Share by Regions (2015-2020)
    • 7.2 China Nuclear Medicine/Radiopharmaceutic Sales and Growth Rate (2015-2020)
    • 7.3 Japan Nuclear Medicine/Radiopharmaceutic Sales and Growth Rate (2015-2020)
    • 7.4 Korea Nuclear Medicine/Radiopharmaceutic Sales and Growth Rate (2015-2020)
    • 7.5 India Nuclear Medicine/Radiopharmaceutic Sales and Growth Rate (2015-2020)
    • 7.6 Southeast Asia Nuclear Medicine/Radiopharmaceutic Sales and Growth Rate (2015-2020)
    • 7.7 Australia Nuclear Medicine/Radiopharmaceutic Sales and Growth Rate (2015-2020)

    8 South America by Country

    • 8.1 South America Nuclear Medicine/Radiopharmaceutic Sales, Revenue and Market Share by Country
      • 8.1.1 South America Nuclear Medicine/Radiopharmaceutic Sales and Market Share by Country (2015-2020)
      • 8.1.2 South America Nuclear Medicine/Radiopharmaceutic Revenue and Market Share by Country (2015-2020)
    • 8.2 Brazil Nuclear Medicine/Radiopharmaceutic Sales and Growth Rate (2015-2020)
    • 8.3 Argentina Nuclear Medicine/Radiopharmaceutic Sales and Growth Rate (2015-2020)

    9 Middle East & Africa by Countries

    • 9.1 Middle East & Africa Nuclear Medicine/Radiopharmaceutic Sales, Revenue and Market Share by Country
      • 9.1.1 Middle East & Africa Nuclear Medicine/Radiopharmaceutic Sales and Market Share by Country (2015-2020)
      • 9.1.2 Middle East & Africa Nuclear Medicine/Radiopharmaceutic Revenue and Market Share by Country (2015-2020)
    • 9.2 Saudi Arabia Nuclear Medicine/Radiopharmaceutic Sales and Growth Rate (2015-2020)
    • 9.3 Turkey Nuclear Medicine/Radiopharmaceutic Sales and Growth Rate (2015-2020)
    • 9.4 Egypt Nuclear Medicine/Radiopharmaceutic Sales and Growth Rate (2015-2020)
    • 9.5 South Africa Nuclear Medicine/Radiopharmaceutic Sales and Growth Rate (2015-2020)

    10 Market Segment by Type

    • 10.1 Global Nuclear Medicine/Radiopharmaceutic Sales and Market Share by Type (2015-2020)
    • 10.2 Global Nuclear Medicine/Radiopharmaceutic Revenue and Market Share by Type (2015-2020)
    • 10.3 Global Nuclear Medicine/Radiopharmaceutic Price by Type (2015-2020)

    11 Global Nuclear Medicine/Radiopharmaceutic Market Segment by Application

    • 11.1 Global Nuclear Medicine/Radiopharmaceutic Sales Market Share by Application (2015-2020)
    • 11.2 Global Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Application (2015-2020)
    • 11.3 Global Nuclear Medicine/Radiopharmaceutic Price by Application (2015-2020)

    12 Market Forecast

    • 12.1 Global Nuclear Medicine/Radiopharmaceutic Sales, Revenue and Growth Rate (2021-2025)
    • 12.2 Nuclear Medicine/Radiopharmaceutic Market Forecast by Regions (2021-2025)
      • 12.2.1 North America Nuclear Medicine/Radiopharmaceutic Market Forecast (2021-2025)
      • 12.2.2 Europe Nuclear Medicine/Radiopharmaceutic Market Forecast (2021-2025)
      • 12.2.3 Asia-Pacific Nuclear Medicine/Radiopharmaceutic Market Forecast (2021-2025)
      • 12.2.4 South America Nuclear Medicine/Radiopharmaceutic Market Forecast (2021-2025)
      • 12.2.5 Middle East & Africa Nuclear Medicine/Radiopharmaceutic Market Forecast (2021-2025)
    • 12.3 Nuclear Medicine/Radiopharmaceutic Market Forecast by Type (2021-2025)
      • 12.3.1 Global Nuclear Medicine/Radiopharmaceutic Sales Forecast by Type (2021-2025)
      • 12.3.2 Global Nuclear Medicine/Radiopharmaceutic Market Share Forecast by Type (2021-2025)
    • 12.4 Nuclear Medicine/Radiopharmaceutic Market Forecast by Application (2021-2025)
      • 12.4.1 Global Nuclear Medicine/Radiopharmaceutic Sales Forecast by Application (2021-2025)
      • 12.4.2 Global Nuclear Medicine/Radiopharmaceutic Market Share Forecast by Application (2021-2025)

    13 Sales Channel, Distributors, Traders and Dealers

    • 13.1 Sales Channel
      • 13.1.1 Direct Marketing
      • 13.1.2 Indirect Marketing
    • 13.2 Distributors, Traders and Dealers

    14 Research Findings and Conclusion

      15 Appendix

      • 15.1 Methodology
      • 15.2 Data Source
      • 15.3 Disclaimer

      Summary:
      Get latest Market Research Reports on Nuclear Medicine/Radiopharmaceutic. Industry analysis & Market Report on Nuclear Medicine/Radiopharmaceutic is a syndicated market report, published as Global Nuclear Medicine/Radiopharmaceutic Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025. It is complete Research Study and Industry Analysis of Nuclear Medicine/Radiopharmaceutic market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      		$3,480.00
      		$5,220.00
      		$6,960.00
      		2,735.28
      		4,102.92
      		5,470.56
      		3,215.52
      		4,823.28
      		6,431.04
      		544,898.40
      		817,347.60
      		1,089,796.80
      		289,849.20
      		434,773.80
      		579,698.40
      Credit card Logo
      Sample Question Discount Download PDF

      Related Reports

      Reason to Buy

      • Trusted By Leaders

        Top executives from leading companies purchase research reports from us. 

      • Shop With Confidence

        We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

      • Customer Centric

        Need assistance related to your research requirements? We are just a phone call or an email away.

      • Personalized Solutions

        Our experienced research specialists are here to help you locate the right reports for your need.

      • Secure Checkout

        Shop without being worried about safety & security of your transactions.
        •

      Request for Sample of this report

      Reports and Markets

      mcafree

      Contact Us

      +1-352-353-0818 (US)

      info@reportsandmarkets.com

      Support

      EMAIL US

      Newsletter

      KEEP UP TO DATE ON ALL THE LATEST REPORTS


      maxmind_logo